Member Info for chester18

The share price has to react this time because either you have a foothold or you don't. If for what ever reason the sp reaches say 2.4 p and then declines mid December I for one will be finding ways to double my holding.

Newcrest know a lot more than this already so when we get to their quarterly in January
there might be even bigger fireworks .

Chester

Fantastic grades and this is only what they want us to know at this stage........

This is way above 2p first thing tomoz.

Wish I'd sold the car, the motor bike and golf clubs last week and bought more GGP.

Chester

Morning Knowlesi

Your prediction of a sub 3p load up is ominously much closer. Even you probably thought that we had moved way past that possibility once the 'UK trial only' had been announced. It's obvious that only having one trial centre open (Nottingham) severely limits the relevant patient density. To get this Combo trial started and have the chance to reach 20 eligible patients we need at least 2 or 3 more sites open asap.

I still think any lowing of the price will be bought into so I'm hoping sub 3p never happens, for all the right reasons .

Chester

The reason I asked the question about the "in ground" value is because there have been many comments about what Hav maybe currently worth. What I wanted to understand was value in the ground based on the bare minimum, does it cover our current Share Price....it seems it covers it easily.
(900,000 ounces @ £100 an ounce = £90M) but that's if a deal was done .

With the fantastic work produced on this BB by PG and 'da Crew' we can see that the work on site and the size of the ore body are both increasing rapidly.
I'm also very confident that once the next 15 hole core values and data are released PG and Crew will help us all understand how far that minimum value has been moved UP.

We should hear news very soon , if not Hav it will be one of the other sites as there's a lot due.
Really happy to be part of this story cos it's got all the ingredients for a very happy ending.

Chester

Can I ask, if there is 3M ounces in Hav and our 30% is 900,000 ounces what is the current going rate for gold that's proved up as a resource?

Chester.

Just checked what has been announced about possible results end 2019.
Verona Pharma,
"Announced that it had completed enrollment in its Phase 2b four-week dose-ranging study evaluating the effect of nebulized ensifentrine as an add-on to inhaled tiotropium, a long acting bronchodilator, in patients with moderate-to-severe COPD.

° Enrollment of 416 patients at 46 sites was completed on schedule with data expected around year end 2019."

Also the next move based on a positive outcome is to talk to the FDA about designing and starting a phase III trial in 2020.

So as has already been said on this board the next trial data being positive is now paramount to the companies future.

Chester.

Hi Rhodi

As you know I have been in this share for a long time. Like yourself at one point I owned around 45k of shares when the price was £1.85 a share. At that point I was in profit, oh for the good old days...

When JK qualifies for these options and pays for them he will need to part with approx £220k which will go straight to the company. I realise at that point they may be worth two or three times that value.
So why issue the options now, is it because the data from two study's are about to be reported and that data is highly positive.
I hope so, not only because it will prove I'm not totally stupid but also prove that ensifentrine is on it's way to becoming a very important stabilising therapy in COPD and Cystic fibrosis. Two conditions that need that breakthrough.
So fingers crossed that I might be right.

All the best
Chester.

Why issue those options now.....?

Could it be that things are about to take a turn for the good.....hmm maybe...

Chester

That 10k sell at 44.49 is my purchase.

News is imminent, any day in the next 30 days. If this data is positive it's time for the share price to start to rise.
I've been here long enough to deserve a positive outcome on my speculative investment.

Just hope there are no special offer come Black Friday.....lol

Chester.

Hi Joey2000

I've only just read your post properly.

If you look back the price surged to 2.4p and fell back to 0.58p. On the next run up it again headed towards 2.4p and then fell back to 1.1p. Just recently it touched 2.1 or 2.2 and retraced to around 1.58 ish. Just wanted to point out to you that I had remembered correctly.

My point was to do with the fact that many PI's confidence has been undermined by these large fluctuations, so we find the price rising on news and then immediately start to retrace. Under normal circumstances the sp would be 2.5p ++ but that past history doesn't help and the traders use it to their advantage.

Still think that solid news on the next 10 - 15 holes will signal a new starting point well above 2p.

Just an opinion but stacks up to me.

Chester.

The reason the share is being held back is down to the previous big run up's to 2.4p and then back down. First time the price collapsed back to 0.58p the second time back to 1.1p. So many PI's got burned.
I would think this share is on the radar of many 100's or 1,000's of potential investors all waiting for a strong signal that the shares going up but this time staying up. Recently there is a big mix of 10% traders and PI's jumping on the first signs of a retrace.
I'm typical of many here, bought at 1.96, 1.82 and 1.7p. I'm glad the price is sticking at around 1.6p so it helps me stay put.
This is currently a traders paradise but that one piece of solid good news is very very close. There's no doubt that Newcrest know just how big this ore body is and by the sounds of all the step outs it seems to be getting even bigger.

If not next weeks AGM or an update next month we will definitely know which way this is going when NC report in January . It's looking so positive plus all the other extras.

All the best, Chester.... : )

Tom111

There are two ways to look at the next fund raiser.
A) Is it to keep the lights on..?
Or
B) Is it to pay for the increased manufacturing capacity and sales growth....?

All fast growing companies need capital.
If the new production comes on line fast enough to boost current sales the company will not be shy about letting the market know how well the year has ended. They could also do the same at the end of January.
My position is that the management of the company has so far been robust.
Buying CellRight in 2017 was not weak but strong aggressive, forward thinking and strategic decision making. They have had to take risks to grow the sales this quickly but the companies products no longer need a hard sell they seem to sell them selves.
It's now a fact that once surgeons and medical staff use Tissue Regenix products they are preferred to any other available treatment, so its repeat, repeat, repeat business , which is why the demand is growing so fast.
If you're looking to trade this share in the short term then its wether sentiment pushes the sp higher or not. If you want to invest for 18 months then n my opinion it's got a very good chance of multi-bagging from the current level.

Chester.

Hi BB123,

You asked why the sp has fallen so sharply.

Simply put the company has persued increased sales very aggressively. If you look back to the product launch in the USA with turnover from virtually zero to where it was last year and then this year's target you will see a very steep upwards graph.
This has been achieved by burning cash with the sole aim to breakeven in 2020-21.
When they bought CellRight in 2017 for £23million they raised £40million at 10p a share. Guess who bought a huge pile...? Woodford...
That raising added 400M shares so it was inevitable that the sp would slide down and reach the 10p.

But then as TRX have burned through the cash we have had the Woodford effect which pushed the price down to 7p then add Brexit and the negativity of any share that's currently not making money , so we reached 5p and more people thought their money was better placed elsewhere. That pressure and the MM's games reduced us to around 3p. The reduction to 0.5p was a massive over reaction and now we sit at 1.5p ish .

The fundamentals of TRX have not changed but the trust and sentiment has. Once they match sales revenues to operating costs and actually start to produce a profit this company will fly either becoming a very large player or being bought out at a huge mark up to the sp.

So short term 3 to 5p is probably a fair price but longer term it has the potential to be very much higher.

But as always, do your own research and invest based on your own findings.

Chester.

Let all not forget where we potentially could be if the FDA had passed the TriGrid 2 in a fair timeframe. Why has it taken very nearly 18 months since our application, and still no answer........

Still feel it's more than just a technical issue...

Chester.

Cracking you've just caused a disturbance in the positivity flux matrix........
Please don't use the thread "Positive Thinking" when you're not actually being positive.

This thread is for happy, partying people with a strong mental constitution who are capable of extraordinary feats of patience.....

Chester......

Excellent, I am buoyed by your responses.
But can you now see how the group happiness manifested itself into a "Post Transitional Positive RNS"....... so let's enjoy the run up to better and better news...

Chester....

Seriously did my post only cheer up TF....!!!

Your all soon distracted with Moditope this and Presentation that......then the price starts to go up and not a flicker to Chester to say thanks for pepping us all up.

Your so Fickle.......

Chester...... : )

To raise the positivity and 'smile ometer ' on this board I thought that it would be a good team member and remind you all that the AvidiMab Collaboration Agreement is already nearly three months in......yeah...!!!
The agreement RNS was released on the 4th September and was for a maximum term of 12 months. So at its max we have already very nearly cleared 25% ..... : )

Plus it could be concluded early which would be very nice indeed..

Hope that has cheered everybody up...... : )

Chester.

"OK Gevass ill give you a dinkum of an demo........ you just pull the dingo apart and out plops the gold"

We were at a low share price of 1.85p before this situation happened. Also the current assets are worth around £33M or 2.8p a share which is where any price correction should head towards.
Add to that the amount currently in the bank plus any profits from current sales.
Once the new laboratories are fitted out manufacturing will increase to meet demand.
The company have already stated that new staff are either already or are being trained ready for the new facilities to come on line.

Lastly if you do your own research you will see that the companies profit margin on sales is approx 60%.

Yes there is money to be made today but TRX in the longer term is a very attractive investment.

Chester.